tiprankstipranks
Clearside Biomedical (CLSD)
NASDAQ:CLSD

Clearside Biomedical (CLSD) Income Statement

889 Followers

Clearside Biomedical Income Statement

Last quarter (Q1 2024), Clearside Biomedical's total revenue was $230.00K, an increase of 5650.00% from the same quarter last year. In Q1, Clearside Biomedical's net income was $-11.76M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.45M$ 8.23M$ 1.33M$ 29.57M$ 7.89M$ 2.17M
Cost of Revenue
$ 355.00K$ 355.00K$ 204.00K---
Gross Profit
$ 8.10M$ 7.87M$ 1.12M$ 29.57M--
Operating Expense
$ 33.69M$ 33.07M$ 31.60M$ -30.20M$ 25.83M$ 32.48M
Operating Income
$ -25.45M$ -24.84M$ -30.28M$ -627.00K$ -17.93M$ -30.30M
Net Non Operating Interest Income Expense
$ 348.00K-----
Other Income Expense
$ 272.00K$ -1.72M$ -669.00K$ -1.00M$ -275.00K$ -466.00K
Pretax Income
$ -25.37M$ -23.13M$ -29.61M$ 376.00K$ -18.21M$ -30.77M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -34.97M$ -32.48M$ -32.95M$ 376.00K$ -18.21M$ -30.77M
Basic EPS
$ -0.55$ -0.53$ -0.55$ 0.01$ -0.39$ -0.81
Diluted EPS
$ -0.55$ -0.53$ -0.55$ 0.01$ -0.39$ -0.81
Basic Average Shares
$ 255.91M$ 61.81M$ 60.20M$ 58.49M$ 46.51M$ 38.17M
Diluted Average Shares
$ 255.91M$ 61.81M$ 60.20M$ 59.91M$ 46.51M$ 38.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 34.04M$ 33.42M$ 31.81M$ -30.20M$ 25.83M$ 32.48M
Net Income From Continuing And Discontinued Operation
$ -34.97M$ -32.48M$ -32.95M$ 376.00K$ -18.21M$ -30.77M
Normalized Income
$ -21.92M$ -18.27M--$ -18.21M$ -30.77M
Interest Expense
------
EBIT
$ -25.37M$ -23.13M$ -29.61M$ 376.00K$ -17.93M$ -30.30M
EBITDA
$ -25.29M$ -23.06M$ -29.46M$ 554.00K$ -17.75M$ -30.09M
Currency in USD

Clearside Biomedical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis